Connaughton Bernadette 4
4 · HALOZYME THERAPEUTICS, INC. · Filed Nov 12, 2025
Insider Transaction Report
Form 4
Connaughton Bernadette
Director
Transactions
- Sale
Common Stock
2025-11-10$68.48/sh−2,000$136,960→ 42,952 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on May 29, 2025 in accordance with Rule 10b5-1.